Transcriptional and metabolic pre-B cell receptor-mediated checkpoints: Implications for autoimmune diseases

Molecular Immunology

Volumn 62, Issue 2, 2014, Pages 315-320

  Zouali, Moncef ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Anergy; Bach 2; Galectin 1; IRF4; IRF8; LAPTMS; Negative selection; Positive selection; Receptor editing; Tolerance

Indexed keywords

LIGAND; PRE B CELL RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BACH2; UNCLASSIFIED DRUG; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 4;

ANTIGEN RECOGNITION; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CELL PROLIFERATION; CELLULAR IMMUNITY; COPY NUMBER VARIATION; GENE; HUMAN; NEGATIVE FEEDBACK; NONHUMAN; PATHOGENESIS; PRE B LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SJOEGREN SYNDROME; TRANSCRIPTION REGULATION; VPREB1 GENE; ANERGY; ANIMAL; AUTOIMMUNE DISEASE; BACH-2; GALECTIN-1; GENETIC TRANSCRIPTION; GENETICS; LAPTMS; METABOLISM; NEGATIVE SELECTION; POSITIVE SELECTION; RECEPTOR EDITING; TOLERANCE;

ANIMALIA; MURINAE;

ANERGY; BACH-2; GALECTIN-1; IRF4; IRF8; LAPTMS; NEGATIVE SELECTION; POSITIVE SELECTION; RECEPTOR EDITING; TOLERANCE;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; PRE-B CELL RECEPTORS; PRECURSOR CELLS, B-LYMPHOID; TRANSCRIPTION, GENETIC;

EID: 84908135475     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.01.009     Document Type: Review

References (63)

1. Azuma T., Takei M., Yoshikawa T., Nagasugi Y., Kato M., Otsuka M., Shiraiwa H., Sugano S., Mitamura K., Sawada S., Masuho Y., Seki N. Identification of candidate genes for Sjögren's syndrome using MRL/lpr mouse model of Sjögren's syndrome and cDNA microarray analysis. Immunol. Lett. 2002, 81:171-176.
2. Baba M., Keller J.R., Sun H.W., Resch W., Kuchen S., Suh H.C., Hasumi H., Hasumi Y., Kieffer-Kwon K.R., Gonzalez C.G., Hughes R.M., Klein M.E., Oh H.F., Bible P., Southon E., Tessarollo L., Schmidt L.S., Linehan W.M., Casellas R. The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dube syndrome is required for murine B-cell development. Blood 2012, 120:1254-1261.
3. Bankovich A.J., Raunser S., Juo Z.S., Walz T., Davis M.M., Garcia K.C. Structural insight into pre-B cell receptor function. Science 2007, 316:291-294.
4. Baum L.G., Blackall D.P., Arias-Magallano S., Nanigian D., Uh S.Y., Browne J.M., Hoffmann D., Emmanouilides C.E., Territo M.C., Baldwin G.C. Amelioration of graft versus host disease by galectin-1. Clin. Immunol. 2003, 109:295-307.
5. Bradl H., Wittmann J., Milius D., Vettermann C., Jack H.M. Interaction of murine precursor B cell receptor with stroma cells is controlled by the unique tail of lambda 5 and stroma cell-associated heparan sulfate. J. Immunol. 2003, 171:2338-2348.
6. Cadera E.J., Wan F., Amin R.H., Nolla H., Lenardo M.J., Schlissel M.S. NF-kappaB activity marks cells engaged in receptor editing. J. Exp. Med. 2009, 206:1803-1816.
7. Cancro M.P. Signalling crosstalk in B cells: managing worth and need. Nat. Rev. Immunol. 2009, 9:657-661.
8. Charles E.D., Brunetti C., Marukian S., Ritola K.D., Talal A.H., Marks K., Jacobson I.M., Rice C.M., Dustin L.B. Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset. Blood 2011, 117:5425-5437.
9. Chen C., Nagy Z., Radic M.Z., Hardy R.R., Huszar D., Camper S.A., Weigert M. The site and stage of anti-DNA B-cell deletion. Nature 1995, 373:252-255.
10. Clark A.G., Weston M.L., Foster M.H. Lack of galectin-1 or galectin-3 alters B cell deletion and anergy in an autoantibody transgene model. Glycobiology 2013, 23:893-903.
11. Elantak L., Espeli M., Boned A., Bornet O., Bonzi J., Gauthier L., Feracci M., Roche P., Guerlesquin F., Schiff C. Structural basis for galectin-1-dependent pre-B cell receptor (pre-BCR) activation. J. Biol. Chem. 2012, 287:44703-44713.
12. Espeli M., Mancini S.J., Breton C., Poirier F., Schiff C. Impaired B-cell development at the pre-BII-cell stage in galectin-1-deficient mice due to inefficient pre-BII/stromal cell interactions. Blood 2009, 113:5878-5886.
13. Flemming A., Brummer T., Reth M., Jumaa H. The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion. Nat. Immunol. 2003, 4:38-43.
14. Hauser J., Verma-Gaur J., Grundstrom T. Broad feedback inhibition of pre-B-cell receptor signaling components. Mol. Immunol. 2013, 54:247-253.
15. Hess J., Werner A., Wirth T., Melchers F., Jack H.M., Winkler T.H. Induction of pre-B cell proliferation after de novo synthesis of the pre-B cell receptor. PNAS 2001, 98:1745-1750.
16. Hikada M., Zouali M. Multistoried roles for B lymphocytes in autoimmunity. Nat. Immunol. 2010, 11:1065-1068.
17. Iqbal A.J., Cooper D., Vugler A., Gittens B.R., Moore A., Perretti M. Endogenous galectin-1 exerts tonic inhibition on experimental arthritis. J. Immunol. 2013, 191:171-177.
18. Kawano Y., Ouchida R., Wang J.Y., Yoshikawa S., Yamamoto M., Kitamura D., Karasuyama H. A novel mechanism for the autonomous termination of pre-B cell receptor expression via induction of lysosome-associated protein transmembrane 5. Mol. Cell. Biol. 2012, 32:4462-4471.
19. Keenan R.A., De Riva A., Corleis B., Hepburn L., Licence S., Winkler T.H., Martensson I.L. Censoring of autoreactive B cell development by the pre-B cell receptor. Science 2008, 321:696-699.
20. Kitamura D., Kudo A., Schaal S., Muller W., Melchers F., Rajewsky K. A critical role of lambda 5 protein in B cell development. Cell 1992, 69:823-831.
21. Kohler F., Hug E., Eschbach C., Meixlsperger S., Hobeika E., Kofer J., Wardemann H., Jumaa H. Autoreactive B cell receptors mimic autonomous pre-B cell receptor signaling and induce proliferation of early B cells. Immunity 2008, 29:912-921.
22. Kruger M.G., Riley R.L. The age-dependent loss of bone marrow B cell precursors in autoimmune NZ mice results from decreased mitotic activity, but not from inherent stromal cell defects. J. Immunol. 1990, 144:103-110.
23. La M., Cao T.V., Cerchiaro G., Chilton K., Hirabayashi J., Kasai K., Oliani S.M., Chernajovsky Y., Perretti M. A novel biological activity for galectin-1: inhibition of leukocyte-endothelial cell interactions in experimental inflammation. Am. J. Pathol. 2003, 163:1505-1515.
24. Lamoureux J.L., Watson L.C., Cherrier M., Skog P., Nemazee D., Feeney A.J. Reduced receptor editing in lupus-prone MRL/lpr mice. J. Exp. Med. 2007, 204:2853-2864.
25. Lian Z.X., Kita H., Okada T., Hsu T., Shultz L.D., Dorshkind K., Ansari A.A., Ikehara S., Naiki M., Gershwin M.E. Increased frequency of pre-pro B cells in the bone marrow of New Zealand Black (NZB) mice: implications for a developmental block in B cell differentiation. Dev. Immunol. 2002, 9:35-45.
26. Liu S.D., Lee S., La Cava A., Motran C.C., Hahn B.H., Miceli M.C. Galectin-1-induced down-regulation of T lymphocyte activation protects (NZB×NZW) F1 mice from lupus-like disease. Lupus 2011, 20:473-484.
27. Lu R., Medina K.L., Lancki D.W., Singh H. IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes Dev. 2003, 17:1703-1708.
28. Ma S., Turetsky A., Trinh L., Lu R. IFN regulatory factor 4 and 8 promote Ig light chain kappa locus activation in pre-B cell development. J. Immunol. 2006, 177:7898-7904.
29. Martin D.A., Lu L., Cascalho M., Wu G.E. Maintenance of surrogate light chain expression induces developmental delay in early B cell compartment. J. Immunol. 2007, 179:4996-5005.
30. McAllister K., Yarwood A., Bowes J., Orozco G., Viatte S., Diogo D., Hocking L.J., Steer S., Wordsworth P., Wilson A.G., Morgan A.W., Kremer J., Pappas D., Gregersen P., Klareskog L., Plenge R., Barton A., Greenberg J., Worthington J., Eyre S. Meta-analysis identifies BACH2 and RAD51B as rheumatoid arthritis susceptibility loci. Arthritis Rheum. 2013, 65:3058-3062.
31. Melchers F. The pre-B-cell receptor: selector of fitting immunoglobulin heavy chains for the B-cell repertoire. Nat. Rev. Immunol. 2005, 5:578-584.
32. Meng W., Li Y., Xue E., Satoh M., Peck A.B., Cohen P.L., Eisenberg R.A., Luning Prak E.T. B-cell tolerance defects in the B6.Aec1/2 mouse model of Sjögren's syndrome. J. Clin. Immunol. 2012, 32:551-564.
33. Meng W., Yunk L., Wang L.S., Maganty A., Xue E., Cohen P.L., Eisenberg R.A., Weigert M.G., Mancini S.J., Prak E.T. Selection of individual VH genes occurs at the pro-B to pre-B cell transition. J. Immunol. 2011, 187:1835-1844.
34. Minegishi Y., Conley M.E. Negative selection at the pre-BCR checkpoint elicited by human mu heavy chains with unusual CDR3 regions. Immunity 2001, 14:631-641.
35. Minegishi Y., Coustan-Smith E., Wang Y.H., Cooper M.D., Campana D., Conley M.E. Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia. J. Exp. Med. 1998, 187:71-77.
36. Minegishi Y., Hendershot L.M., Conley M.E. Novel mechanisms control the folding and assembly of lambda5/14.1 and VpreB to produce an intact surrogate light chain. PNAS 1999, 96:3041-3046.
37. Nahar R., Ramezani-Rad P., Mossner M., Duy C., Cerchietti L., Geng H., Dovat S., Jumaa H., Ye B.H., Melnick A., Muschen M. Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC. Blood 2011, 118:4174-4178.
38. Osmond D.G. Proliferation kinetics and the lifespan of B cells in central and peripheral lymphoid organs. Curr. Opin. Immunol. 1991, 3:179-185.
39. Panigrahi A.K., Goodman N.G., Eisenberg R.A., Rickels M.R., Naji A., Luning Prak E.T. RS rearrangement frequency as a marker of receptor editing in lupus and type 1 diabetes. J. Exp. Med. 2008, 205:2985-2994.
40. Park H., Staehling K., Tsang M., Appleby M.W., Brunkow M.E., Margineantu D., Hockenbery D.M., Habib T., Liggitt H.D., Carlson G., Iritani B.M. Disruption of Fnip1 reveals a metabolic checkpoint controlling B lymphocyte development. Immunity 2012, 36:769-781.
41. Parker M.J., Licence S., Erlandsson L., Galler G.R., Chakalova L., Osborne C.S., Morgan G., Fraser P., Jumaa H., Winkler T.H., Skok J., Martensson I.L. The pre-B-cell receptor induces silencing of VpreB and lambda5 transcription. EMBO J. 2005, 24:3895-3905.
42. Pathak S., Ma S., Shukla V., Lu R. A role for IRF8 in B cell anergy. J. Immunol. 2013, 191:6222-6230.
43. Pelkonen P., Lahdenne P., Lantto R., Honkanen V. Chronic arthritis associated with chromosome deletion 22q11.2 syndrome. J. Rheumatol. 2002, 29:2648-2650.
44. Rabinovich G.A., Toscano M.A. Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat. Rev. Immunol. 2009, 9:338-352.
45. Radic M.Z., Zouali M. Receptor editing, immune diversification, and self-tolerance. Immunity 1996, 5:505-511.
46. Rickert R.C. New insights into pre-BCR and BCR signalling with relevance to B cell malignancies. Nat. Rev. Immunol. 2013, 13:578-591.
47. Sakaguchi N., Melchers F. Lambda 5, a new light-chain-related locus selectively expressed in pre-B lymphocytes. Nature 1986, 324:579-582.
48. Santucci L., Fiorucci S., Rubinstein N., Mencarelli A., Palazzetti B., Federici B., Rabinovich G.A., Morelli A. Galectin-1 suppresses experimental colitis in mice. Gastroenterology 2003, 124:1381-1394.
49. Schwartz R.S., Stollar B.D. Heavy-chain directed B-cell maturation: continuous clonal selection beginning at the pre-B cell stage. Immunol. Today 1994, 15:27-32.
50. Sullivan K.E., McDonald-McGinn D.M., Driscoll D.A., Zmijewski C.M., Ellabban A.S., Reed L., Emanuel B.S., Zackai E.H., Athreya B.H., Keenan G. Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome). Arthritis Rheum. 1997, 40:430-436.
51. Swaminathan S., Huang C., Geng H., Chen Z., Harvey R., Kang H., Ng C., Titz B., Hurtz C., Sadiyah M.F., Nowak D., Thoennissen G.B., Rand V., Graeber T.G., Koeffler H.P., Carroll W.L., Willman C.L., Hall A.G., Igarashi K., Melnick A., Muschen M. BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint. Nat. Med. 2013, 19:1014-1022.
52. Tabrizi S.J., Niiro H., Masui M., Yoshimoto G., Iino T., Kikushige Y., Wakasaki T., Baba E., Shimoda S., Miyamoto T., Hara T., Akashi K. T cell leukemia/lymphoma 1 and galectin-1 regulate survival/cell death pathways in human naive and IgM+ memory B cells through altering balances in Bcl-2 family proteins. J. Immunol. 2009, 182:1490-1499.
53. ten Boekel E., Melchers F., Rolink A.G. Changes in the V(H) gene repertoire of developing precursor B lymphocytes in mouse bone marrow mediated by the pre-B cell receptor. Immunity 1997, 7:357-368.
54. Tsai C.M., Guan C.H., Hsieh H.W., Hsu T.L., Tu Z., Wu K.J., Lin C.H., Lin K.I. Galectin-1 and galectin-8 have redundant roles in promoting plasma cell formation. J. Immunol. 2011, 187:1643-1652.
55. van Loo P.F., Dingjan G.M., Maas A., Hendriks R.W. Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling. Immunity 2007, 27:468-480.
56. Vettermann C., Herrmann K., Albert C., Roth E., Bosl M.R., Jack H.M. A unique role for the lambda5 nonimmunoglobulin tail in early B lymphocyte development. J. Immunol. 2008, 181:3232-3242.
57. Viau M., Zouali M. B-lymphocytes, innate immunity, and autoimmunity. Clin. Immunol. 2005, 114:17-26.
58. Wang Y.H., Stephan R.P., Scheffold A., Kunkel D., Karasuyama H., Radbruch A., Cooper M.D. Differential surrogate light chain expression governs B-cell differentiation. Blood 2002, 99:2459-2467.
59. Yim S.H., Chung Y.J., Jin E.H., Shim S.C., Kim J.Y., Kim Y.S., Hu H.J., Shin S.H., Pae H.O., Zouali M., Chung H.T. The potential role of VPREB1 gene copy number variation in susceptibility to rheumatoid arthritis. Mol. Immunol. 2011, 48:1338-1343.
60. Zouali M. Human pathogenic autoantibodies and their escape from deletion. Ann. N.Y. Acad. Sci. 1995, 764:436-439.
61. Zouali M. Receptor editing and receptor revision in rheumatic autoimmune diseases. Trends Immunol. 2008, 29:103-109.
62. Zouali M. Tweaking the B lymphocyte compartment in autoimmune diseases. Nat. Immunol. 2014, in press.
63. The Epigenetics of Autoimmune Diseases 2009, Wiley-Blackwell, (an imprint of John Wiley & Sons Ltd) (April 3 2009). M. Zouali (Ed.).